Best way to revascularize patients with main stem and three-vessel lesions. Patients should be operated!
Standard
Best way to revascularize patients with main stem and three-vessel lesions. Patients should be operated! / Reichenspurner, H; Conradi, L; Cremer, J; Mohr, F W.
In: CLIN RES CARDIOL, Vol. 99, No. 9, 09.2010, p. 541-544.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Best way to revascularize patients with main stem and three-vessel lesions. Patients should be operated!
AU - Reichenspurner, H
AU - Conradi, L
AU - Cremer, J
AU - Mohr, F W
PY - 2010/9
Y1 - 2010/9
N2 - Despite established guidelines for the treatment of coronary artery disease (CAD) by either coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI), everyday clinical practice has proven to differ substantially with even the most complex coronary lesions being targeted by PCI today. However, an abundancy of clinical trials, both observational and randomized has proven the superiority of coronary surgery over PCI in almost every type of multivessel or left main CAD in symptomatic patients. This holds true also for 'hard' endpoints like cardiac death or myocardial infarction as recently demonstrated by the landmark SYNTAX trial. These results have lead to the wording of appropriateness criteria, which integrate current guidelines, evidence from clinical trials and interdisciplinary expert opinion and which express essentially the same message as the SYNTAX trial: "CABG remains the standard of care for patients with three-vessel or left main coronary artery disease"
AB - Despite established guidelines for the treatment of coronary artery disease (CAD) by either coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI), everyday clinical practice has proven to differ substantially with even the most complex coronary lesions being targeted by PCI today. However, an abundancy of clinical trials, both observational and randomized has proven the superiority of coronary surgery over PCI in almost every type of multivessel or left main CAD in symptomatic patients. This holds true also for 'hard' endpoints like cardiac death or myocardial infarction as recently demonstrated by the landmark SYNTAX trial. These results have lead to the wording of appropriateness criteria, which integrate current guidelines, evidence from clinical trials and interdisciplinary expert opinion and which express essentially the same message as the SYNTAX trial: "CABG remains the standard of care for patients with three-vessel or left main coronary artery disease"
KW - Angioplasty, Balloon, Coronary
KW - Coronary Artery Bypass
KW - Coronary Artery Disease/surgery
KW - Humans
KW - Randomized Controlled Trials as Topic
KW - Severity of Illness Index
KW - Treatment Outcome
U2 - 10.1007/s00392-010-0190-2
DO - 10.1007/s00392-010-0190-2
M3 - SCORING: Journal article
C2 - 20617323
VL - 99
SP - 541
EP - 544
JO - CLIN RES CARDIOL
JF - CLIN RES CARDIOL
SN - 1861-0684
IS - 9
ER -